AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: Raymond, E Faivre, S Weiss, G McGill, J Davidson, K Izbicka, E Kuhn, JG Allred, C Clark, GM Von Hoff, DD
Citation: E. Raymond et al., Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas, CLIN CANC R, 7(5), 2001, pp. 1171-1180

Authors: Miller, CT Weragoda, R Izbicka, E Iverson, BL
Citation: Ct. Miller et al., The synthesis and screening of 1,4,5,8-naphthalenetetracarboxylic diimide-peptide conjugates with antibacterial activity, BIO MED CH, 9(8), 2001, pp. 2015-2024

Authors: Petit, T Davidson, KK Lawrence, RA von Hoff, DD Izbicka, E
Citation: T. Petit et al., Neuropeptide receptor status in human tumor cell lines, ANTI-CANC D, 12(2), 2001, pp. 133-136

Authors: Izbicka, E Barnes, LD Robinson, AK Davidson, KK Lawrence, RA Hannibal, GT
Citation: E. Izbicka et al., Alterations in DNA repair and telomere maintenance mechanism affect response to porphyrins in yeast, ANTICANC R, 21(3B), 2001, pp. 1899-1903

Authors: Hammond, LA Davidson, K Lawrence, R Camden, JB Von Hoff, DD Weitman, S Izbicka, E
Citation: La. Hammond et al., Exploring the mechanisms of action of FB642 at the cellular level, J CANC RES, 127(5), 2001, pp. 301-313

Authors: Rha, SY Izbicka, E Lawrence, R Davidson, K Sun, DK Moyer, MP Roodman, GD Hurley, L Von Hoff, D
Citation: Sy. Rha et al., Effect of telomere and telomerase interactive agents on human tumor and normal cell lines, CLIN CANC R, 6(3), 2000, pp. 987-993

Authors: Tolcher, AW Aylesworth, C Rizzo, J Izbicka, E Campbell, E Kuhn, J Weiss, G Von Hoff, DD Rowinsky, EK
Citation: Aw. Tolcher et al., A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenousinfusion in patients with advanced solid tumors, ANN ONCOL, 11(3), 2000, pp. 333-338

Authors: Soda, H Raymond, E Sharma, S Lawrence, R Davidson, K Oka, M Kohno, S Izbicka, E Von Hoff, DD
Citation: H. Soda et al., Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro, PROSTATE, 43(3), 2000, pp. 161-168

Authors: Izbicka, E Sommer, E Skopinska-Rozewska, E Davidson, K Wu, RS Orlowski, T Pastewka, K
Citation: E. Izbicka et al., Tetracationic porphyrins inhibit angiogenesis induced by human tumor cellsin vivo, ANTICANC R, 20(5A), 2000, pp. 3205-3210

Authors: Raymond, E Soria, JC Izbicka, E Boussin, F Hurley, L Von Hoff, DD
Citation: E. Raymond et al., DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs, INV NEW DR, 18(2), 2000, pp. 123-137

Authors: Hurley, LH Wheelhouse, RT Sun, D Kerwin, SM Salazar, M Fedoroff, OY Han, FX Han, HY Izbicka, E Von Hoff, DD
Citation: Lh. Hurley et al., G-quadruplexes as targets for drug design, PHARM THERA, 85(3), 2000, pp. 141-158

Authors: Petit, T Davidson, K Izbicka, E Von Hoff, DD
Citation: T. Petit et al., Elimination of extrachromosomal c-myc genes by hydroxyurea induces apoptosis, APOPTOSIS, 4(3), 1999, pp. 163-167

Authors: Hidalgo, M Izbicka, E Eckhardt, SG MacDonald, JR Cerna, C Gomez, L Rowinsky, EK Weitman, SD Von Hoff, DD
Citation: M. Hidalgo et al., Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units, ANTI-CANC D, 10(9), 1999, pp. 837-844

Authors: Lawrence, RA Izbicka, E De Jager, RL Tohgo, A Clark, GM Weitman, SD Rowinsky, EK Von Hoff, DD
Citation: Ra. Lawrence et al., Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells, ANTI-CANC D, 10(7), 1999, pp. 655-661

Authors: Hidalgo, M Izbicka, E Cerna, C Gomez, L Rowinsky, EK Weitman, SD Von Hoff, DD
Citation: M. Hidalgo et al., Comparative activity of the cyclopropylpyrroloindole compounds adozelesin,bizelesin and carzelesin in a human tumor colony-forming assay, ANTI-CANC D, 10(3), 1999, pp. 295-302

Authors: Diab, SG Hilsenbeck, SG Izbicka, E Weitman, SD Von Hoff, DD
Citation: Sg. Diab et al., Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system, ANTI-CANC D, 10(3), 1999, pp. 303-307

Authors: Petit, T Izbicka, E Lawrence, RA Nalin, C Weitman, SD Von Hoff, DD
Citation: T. Petit et al., Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units, ANTI-CANC D, 10(3), 1999, pp. 309-315

Authors: Soda, H Raymond, E Sharma, S Lawrence, R Cerna, C Gomez, L Schaub, R Von Hoff, DD Izbicka, E
Citation: H. Soda et al., Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors, ANTI-CANC D, 10(1), 1999, pp. 97-101

Authors: Petit, T Izbicka, E Lawrence, RA Bishop, WR Weitman, S Von Hoff, DD
Citation: T. Petit et al., Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units, ANN ONCOL, 10(4), 1999, pp. 449-453

Authors: Dunstan, CR Boyce, R Boyce, BF Garrett, IR Izbicka, E Burgess, WH Mundy, GR
Citation: Cr. Dunstan et al., Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats, J BONE MIN, 14(6), 1999, pp. 953-959

Authors: Britten, CD Izbicka, E Hilsenbeck, S Lawrence, R Davidson, K Cerna, C Gomez, L Rowinsky, EK Weitman, S Von Hoff, DD
Citation: Cd. Britten et al., Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay, CANC CHEMOT, 44(2), 1999, pp. 105-110

Authors: Izbicka, E Nishioka, D Marcell, V Raymond, E Davidson, KK Lawrence, RA Wheelhouse, RT Hurley, LH Wu, RS Von Hoff, DD
Citation: E. Izbicka et al., Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos, ANTI-CAN DR, 14(4), 1999, pp. 355-365

Authors: Izbicka, E Macdonald, JR Davidson, K Lawrence, RA Gomez, L Von Hoff, DD
Citation: E. Izbicka et al., 5,6 dihydro-5 '-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells, ANTICANC R, 19(2A), 1999, pp. 1285-1291

Authors: Izbicka, E Davidson, KK Lawrence, RA MacDonald, JR Von Hoff, DD
Citation: E. Izbicka et al., 5,6-dihydro-5 '-azacytidine (DHAC) affects estrogen sensitivity in estrogen-refractory human breast carcinoma cell lines, ANTICANC R, 19(2A), 1999, pp. 1293-1298

Authors: Izbicka, E Davidson, K Lawrence, R Cote, R MacDonald, JR Von Hoff, DD
Citation: E. Izbicka et al., Cytotoxic effects of MGI 114 are independent of tumor p53 or p21 expression, ANTICANC R, 19(2A), 1999, pp. 1299-1307
Risultati: 1-25 | 26-28